Top Markets
Coin of the day
BioPorto A/S BioPorto A/S

BioPorto A/S

BIOPOR
Clasificación en acciones #21789
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Precio por acción
$0.20243542
Última sincronización: 2026-08-21
Capitalización bursátil
$100.22M
Cambio (1 día)
2.00%
Cambio (1 año)
-0.82%
País
DK
Comercio BioPorto A/S (BIOPOR)

Categoría

Ganancias de BioPorto A/S (BIOPOR)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di BioPorto A/S, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de BioPorto A/S desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.58B -
US